The advanced role of carbon quantum dots in nanomedical applications
Carbon quantum dots (CQDs) have emerged as a potential material in the diverse fields of
biomedical applications due to their numerous advantageous properties including …
biomedical applications due to their numerous advantageous properties including …
Pharmacologic resistance in colorectal cancer: a review
WA Hammond, A Swaika… - Therapeutic advances in …, 2016 - journals.sagepub.com
Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …
both men and women worldwide. This is in spite of widespread, effective measures of …
[PDF][PDF] Management of brain metastases in tyrosine kinase inhibitor-naïve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi …
WJ Magnuson, NH Lester-Coll, AJ Wu… - J Clin …, 2017 - clf1.medpagetoday.com
Purpose Stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and epidermal
growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are treatment options for …
growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are treatment options for …
[HTML][HTML] Probiotics: a promising candidate for management of colorectal cancer
Simple Summary Colorectal cancer being the third most frequently diagnosed cancer type,
is creating enormous physical, financial, and emotional burden on individuals as well as on …
is creating enormous physical, financial, and emotional burden on individuals as well as on …
[HTML][HTML] Brain tumor-targeted drug delivery strategies
X Wei, X Chen, M Ying, W Lu - Acta pharmaceutica sinica B, 2014 - Elsevier
Despite the application of aggressive surgery, radiotherapy and chemotherapy in clinics,
brain tumors are still a difficult health challenge due to their fast development and poor …
brain tumors are still a difficult health challenge due to their fast development and poor …
[HTML][HTML] EGFR-Based targeted therapy for colorectal cancer—Promises and challenges
B Janani, M Vijayakumar, K Priya, JH Kim… - Vaccines, 2022 - mdpi.com
Colorectal carcinoma (CRC) is the most lethal and common form of cancer in the world. It
was responsible for almost 881,000 cancer deaths in 2018. Approximately 25% of cases are …
was responsible for almost 881,000 cancer deaths in 2018. Approximately 25% of cases are …
EGFR signaling in colorectal carcinoma
AM Krasinskas - Pathology research international, 2011 - Wiley Online Library
The epidermal growth factor receptor (EGFR) and its downstream signaling pathways are
involved in the development and progression of several human tumors, including colorectal …
involved in the development and progression of several human tumors, including colorectal …
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review
J Tol, CJA Punt - Clinical therapeutics, 2010 - Elsevier
Background: Two groups of agents targeting either the vascular endothelial growth factor
(VEGF) receptor or the epidermal growth factor receptor (EGFR) have been added to the …
(VEGF) receptor or the epidermal growth factor receptor (EGFR) have been added to the …
[HTML][HTML] SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: A novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid …
Background Barely 10-20% of patients with metastatic colorectal cancer (mCRC) receive a
clinical benefit from the use of anti-EGFR monoclonal antibodies (mAbs). We hypothesized …
clinical benefit from the use of anti-EGFR monoclonal antibodies (mAbs). We hypothesized …
The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery
C Zhan, W Lu - Current pharmaceutical biotechnology, 2012 - ingentaconnect.com
Treatment of malignant gliomas remains a challenge irrespective of the recent
improvements. Chemotherapeutic agents for malignant gliomas have been particularly …
improvements. Chemotherapeutic agents for malignant gliomas have been particularly …